WO1994012145A2 - Cosmetic composition - Google Patents

Cosmetic composition Download PDF

Info

Publication number
WO1994012145A2
WO1994012145A2 PCT/EP1993/003358 EP9303358W WO9412145A2 WO 1994012145 A2 WO1994012145 A2 WO 1994012145A2 EP 9303358 W EP9303358 W EP 9303358W WO 9412145 A2 WO9412145 A2 WO 9412145A2
Authority
WO
WIPO (PCT)
Prior art keywords
composition according
surfactant
cells
gas
gas cells
Prior art date
Application number
PCT/EP1993/003358
Other languages
French (fr)
Other versions
WO1994012145A3 (en
Inventor
Rodney David Bee
David Needham
Original Assignee
Unilever Plc
Unilever N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Plc, Unilever N.V. filed Critical Unilever Plc
Priority to AU56293/94A priority Critical patent/AU5629394A/en
Priority to JP6512784A priority patent/JPH08503936A/en
Priority to EP94901923A priority patent/EP0690708A1/en
Publication of WO1994012145A2 publication Critical patent/WO1994012145A2/en
Publication of WO1994012145A3 publication Critical patent/WO1994012145A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/046Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • A61K9/122Foams; Dry foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair

Definitions

  • This invention relates to cosmetic and pharmaceutical compositions, in particular aerated pastes, creams and lotions intended for topical application to the skin, hair, mucosae and teeth.
  • a problem encountered with many products, including cosmetic compositions, containing gas cells is the stability with time: this is because a gas cell dispersion comprising large cells is vulnerable to creaming separation of the dispersion into discrete layers of different gas phase volume, the larger cells in the high gas phase volume layer will coalesce through film rupture, while the smaller gas cells, say under 100 ⁇ m, are unstable with time, due to disproportionation in favour of larger cells and this is in particular true if the gas cells become finer.
  • US4,588,582 discloses modifying the appearance of toothpaste by incorporation therein of 10 to 20% of a gas in the form of discrete bubbles having a diameter in the range of from 10 to 30 microns to give stability.
  • EP 521 543 describes gas cells dispersed in a continuous liquid medium in a stable condition, ie having a stability in excess of two weeks, the gas cells having a measured d3,2 average diameter of less than 20 ⁇ m.
  • the boundary surface of each cell that is the surface separating the gas of each cell and the rest of the product, is preferably structured and comprises a multitude of adjacent domes. Specific stability is obtained if the great majority of the domes have hexagonal and some pentagonal outlines. Usually, some irregularities, for example higher polygons, are present amongst the domed structures. These polygons can be of very irregular shape.
  • the regular domed surface is absent and may then be smooth or buckled.
  • Gas cells of a good stability with respect to creaming and disproportionation are obtained when the cells have diameters in the range from 0.1 to 20 ⁇ m and more preferably from 0.5 to 3 ⁇ m. Diameter throughout this description and claims refers to a measured d3,2 (volume surface) average diameter.
  • liquid medium in this description and claims means any medium showing molecule mobility, ie including gels and viscous liquids.
  • a suitable method of preparing a multitude of gas cells in a liquid medium comprises whipping a liquid medium with a gas such that gas cells of the required dimension are formed while having a surface active agent contained in that liquid medium for stabilising the gas cells.
  • a gas such that gas cells of the required dimension are formed while having a surface active agent contained in that liquid medium for stabilising the gas cells.
  • sufficient shear should be exerted on the larger gas cells that initially are formed. Factors influencing this shear are the type of mixer or beater or whisk, the viscosity of the liquid medium and the temperature thereof.
  • a high shear, mixer such as a Kenwood Chef mixer, a colloid mill, an Oakes mixer, a cavity transfer mixer or a Silverson will be used.
  • a Kenwood Chef mixer By increasing the viscosity and/or lowering the temperature of the liquid medium the size reducing effect of the mixer on the gas cells is increased.
  • a Kenwood Chef mixer is used at room temperature a suitable dynamic viscosity of the liquid medium is preferably from 0.1 Pa.s to 20 Pa.s although the range of from 0.2 to 0.4 Pa.s is preferred.
  • this foam is then aged.
  • Stable gas, cells may then be separated from part of the liquid medium used for preparing the cells. Separation can be achieved by centrifuging or using a dialysis membrane after modifying the liquid phase of the gas cell suspension such as by dilution with a miscible fluid.
  • this gas cells ingredient in the compositions of the invention provides improved creaminess in texture, a whiter more opaque product and, dependent on components, enhanced fragrance, flavour, or improved skin or mouthfeel.
  • suspensions of gas cells prepared as described can be used to replace, or improve on, some of the attributes normally contributed by the oil/fat in cosmetic or pharmaceutical emulsions.
  • the invention provides a cosmetic or pharmaceutical composition
  • a preformed gas cells ingredient comprising a surfactant, in which the gas cells have a d3,2 average particle size of less than 20 ⁇ m and a stability in excess of 2 weeks.
  • the invention is founded on the preparation of an ingredient comprising a large number of very stable gas cells of very small size. When such cells are present in bulk they will form about 10 8 to about 10 10 per ml. On incorporation of this ingredient into a cosmetic or pharmaceutical composition, it is preferably distributed throughout the mass in the form of discrete cells so as to provide the benefits associated with their presence. However it must be expected that the cells are lilekly to form flocculates in the composition.
  • the stable gas cells whether present in discrete form or as flocculates, are distinguished from any gas cells of a larger size that may be present. The latter is not in the form of stable cells, but contributes most of the volume.
  • the gas cell number concentration in the composition will be above about 10 6 per ml, preferably above 10 7 per ml, with the number and size selected to provide the desired benefit.
  • the particle size of the gas cells is less than 20 ⁇ m, more preferred 0.1 to 10 ⁇ m, most preferred from 1 to 6 ⁇ m.
  • the gas cells ingredient for use in compositions of the invention have a stability in excess of 2 weeks. With this is meant that upon storage for 2 weeks at 4°C more than 90% by number of the gas cells in the composition still remain intact.
  • compositions, wherein the stability of the gas cells is more than 4 weeks, most preferably more than 8 weeks.
  • the gas cells ingredient can be prepared from a cosmetically acceptable surface active material suitable for the making of gas cells with structured surfaces, that is a surfactant whose head group does not carry a substantial charge, compared to that of an ionised anionic or cationic surfactant, and whose head group also occupies a similar surface area to that of the tail group, such that the tail group is capable of crystallising at the storage temperature of the composition.
  • the tail group of the surfactant is saturated and has a carbon chain of at least 14, preferably from 16 to 22 carbon atoms, for products to be held at room temperature or slightly higher.
  • Suitable surfactants are nonionic or virtually so in character, for example mono-, di- or tri-long chain fatty acid esters of sucrose or distearoyl or dipalmitoyl phosphatidylcholine or mixtures thereof.
  • any suitable thickener may be present in the system while forming the stable gas cells.
  • suitable thickener materials are for example sugars, (hydroxy-alkyl) celluloses, hydrolysed starches and mixtures thereof.
  • compositions containing the gas cells in accordance to the invention it is desirable to prepare the gas cells in bulk separately and add these as an ingredient to the composition during or after its preparation.
  • a suitable method of pre-preparing the gas cells ingredient involves the preparation of an aqueous solution of the desired viscosity (for example by using a thickener material at a suitable level) and containing 0.1 to 20 wt% of surfactant (s).
  • surfactant s
  • the selection of the surfactant is critical to the subsequent stability of the gas cells. It is restricted to those providing the surface characteristics as described earlier.
  • Gas cells are mechanically incorporated into the aqueous solution and then comminuted by suitable agitation, preferably at high shear, until a system is formed wherein the average particle size of the gas cells is within the limits as herein before described.
  • gas cells according to the invention can if desired "be manufactured without the use of a separate component to contribute the principal part of the viscosity.
  • the cosmetic or pharmaceutical compositions of the invention into which the gas cells are incorporated, as a separate ingredient can be any composition which is suitable for topical application to the skin, hair, mucosae or the teeth.
  • the ingredients of such composition in addition to the gas cells will be those that are conventionally employed by manufacturers and formulations of cosmetic and pharmaceutical compositions.
  • the gas cells can be employed to enhance delivery, during topical application, of active materials that can benefit the skin, hair, mucosae or teeth.
  • co-surfactants containing suitable lipid chains may be incorporated into the structured gas cell surface.
  • the co surfactant is molecularly dispersed within the interface.
  • the stable gas cells therefore provide a favourable vehicle both to hold and to deposit beneficial surface active species onto a surface.
  • beneficial surface active species such as ceramides may be included into and deposited from such structures.
  • the gas cells When the composition is in liquid or semi liquid form, the gas cells can be employed to enhance the appearance of the composition.
  • gas cells of the present invention scatter light very effectively. Consequently, a concentrated suspension for example, greater than 10 7 cells ml -1 when present in a suitable support medium can be used as a barrier to light radiation.
  • Such cells can be used to replace or augment organic sunscreens or solid inorganic pigments, such as ultra fine titanium dioxide, which are currently used in sunscreen creams and lotions.
  • the amount of gas cells that can usefully be incorporated into compositions in accordance with the invention, as a preformed gas cells ingredient is from 0.001 to 80%, preferably from 0.1 to 10% by volume of the composition.
  • aqueous solution was prepared containing 70% by wt of maltodextrin 63DE and 2% by wt of sucrose mono stearate ester. Using a Kenwood chef mixer this solution was whipped with air for l hour at speed 5. A thick creamy foam resulted.
  • This foam showed an air phase volume of 0.6 and the great majority of the gas cells had a diameter of the order of 2 ⁇ m and below. On standing for 40 days little visible change had occurred in these cells.
  • Electron microscopy photographs showed (see Figures 1 and 2) that the air cells had surfaces compartmentalised into domes, most of the domes having a hexagonal and some pentagonal outline. Few showed a differently polygonal outline: See in particular, Figure 2.
  • a representation showing part of a domed surface and made with the largest magnification factor is shown in Fig 3.
  • the foam as prepared could be diluted 1000 times with water resulting in a white milky liquid. The same result was obtained on 1000 times dilution with a 30% by wt aqueous maltodextrin 63DE solution. Though no longer suspended/dispersed in a thick viscous aqueous liquid the gas cells with diameters less than 5-10 ⁇ m remained in suspension, although with some creaming. This creaming could be reversed by simple stirring or swirling. No significant change took place over 20 days.
  • the gas cells could be concentrated again to a gas phase volume of 0.4 by centrifuging the diluted liquid in a centrifuge at a speed of 2500 rpm for 5 minutes.
  • the rate of concentration of the gas cells by centrifugation could be manipulated by varying the viscosity of the suspending phase and by the magnitude of the applied gravitational force.
  • the thick foam prepared by the method just described was diluted with distilled water to air phase volumes ⁇ of 0.1, 0.01 and 0.001 respectively. After standing for 14 days, gas cell size determinations were made both with a Coulter Counter (aperture size 70 ⁇ m) and a Malvern Zetasizer.
  • samples of each of the three amounts of diluted foams were taken after gently shaking and these samples were diluted with distilled water to a dilution suitable for the determination.
  • a blank gas cell size determination of distilled water resulted in a total background count from particulate impurities of 600.
  • An amount of the original foam was diluted with distilled water to an air phase volume of 0.05 and dialysed against distilled water overnight to reduce the maltodextrin in the liquid phase.
  • gas microcells had typical diameters in the range 1 to 10 ⁇ m.
  • the microcells could be seen to be freely mobile both in the flowing liquid on the microscope slide and to be moving under the influence of Brownian motion.
  • an increased proportion of gas microcells relative to larger cells could be formed.
  • the gas cell suspension After dilution to a viscosity which allowed removal of cells larger than the required size (in this case 20 ⁇ m) and separation by creaming, the gas cell suspension had a phase volume of gas of ⁇ 0.4 and contained in the region of 10 9 cells per ml. If required, excess surfactant could be removed by dialysis.
  • Gas microcells prepared in this way could be mixed with solutions containing a gelling or a viscosity imparting agent with appropriate yield strength properties to produce a suspension of known phase volume which is substantially stable to creaming of the cells. With suitable microbiological precautions the gas cell suspension remained unchanged over a period of many weeks.
  • Gas microcells have been prepared using a mixture of two types of surfactants having different head group sizes but the same or very similar saturated hydrophobic chains.
  • This experiment illustrates that microcells of substantial stability can be prepared by the addition of various amounts of co-surfactant(s) in which the characteristic surface dome features can be expanded such that the radius of the dome is modified to become more (or less) similar to that of the gas cell surface.
  • This can be illustrated by transmission electron micrograph ( Figure 4).
  • the sample was prepared by the procedure of Experiment 1 but from a composition of surfactants of sucrose ester (1.3 w/v) and stearic acid (0.07% w/v). In such microcells the regular pattern is disturbed. Whilst the cell surface remains curved and separated into domains, these are no longer regular.
  • PC phosphatidylcholine
  • a phase volume of typically 0.7 was obtained in the initial aeration step. After ageing for 24 hours the foam comprising microcells could be stripped of the larger cells by creaming.
  • Example 1 The invention is illustrated by Examples 1 and 2 which define skin cream compositions, each containing a preformed gas microcell suspension prepared as described in Experiment 1.
  • Example 1
  • This example illustrates an oil-in-water skin cream in accordance with the invention.
  • Alfol 16RD is cetyl alcohol
  • the suncare cream had the following formulation:
  • PARSOL 1789 is 4-(1,1-dimethylethyl)-4'- methoxydibenzoylmethane
  • PARSOL MCX is octyl methoxycinnamate

Abstract

A cosmetic or pharmaceutical composition suitable for topical application comprises stable gas cells having d3,2 average particle size below 20νm.

Description

COSMETIC COMPOSITION
FIELD OF THE INVENTION This invention relates to cosmetic and pharmaceutical compositions, in particular aerated pastes, creams and lotions intended for topical application to the skin, hair, mucosae and teeth. BACKGROUND TO THE INVENTION
A problem encountered with many products, including cosmetic compositions, containing gas cells is the stability with time: this is because a gas cell dispersion comprising large cells is vulnerable to creaming separation of the dispersion into discrete layers of different gas phase volume, the larger cells in the high gas phase volume layer will coalesce through film rupture, while the smaller gas cells, say under 100μm, are unstable with time, due to disproportionation in favour of larger cells and this is in particular true if the gas cells become finer.
US4,588,582 (Lever Brothers Company) discloses modifying the appearance of toothpaste by incorporation therein of 10 to 20% of a gas in the form of discrete bubbles having a diameter in the range of from 10 to 30 microns to give stability.
EP 521 543 describes gas cells dispersed in a continuous liquid medium in a stable condition, ie having a stability in excess of two weeks, the gas cells having a measured d3,2 average diameter of less than 20μm.
The boundary surface of each cell, that is the surface separating the gas of each cell and the rest of the product, is preferably structured and comprises a multitude of adjacent domes. Specific stability is obtained if the great majority of the domes have hexagonal and some pentagonal outlines. Usually, some irregularities, for example higher polygons, are present amongst the domed structures. These polygons can be of very irregular shape.
In the cases where the surfactant packs in an approximately planar film at the microcell surface, the regular domed surface is absent and may then be smooth or buckled. Gas cells of a good stability with respect to creaming and disproportionation are obtained when the cells have diameters in the range from 0.1 to 20μm and more preferably from 0.5 to 3μm. Diameter throughout this description and claims refers to a measured d3,2 (volume surface) average diameter. The expression "liquid medium" in this description and claims means any medium showing molecule mobility, ie including gels and viscous liquids.
A suitable method of preparing a multitude of gas cells in a liquid medium is also described in EP 521 543 and comprises whipping a liquid medium with a gas such that gas cells of the required dimension are formed while having a surface active agent contained in that liquid medium for stabilising the gas cells. For obtaining the gas cells of the required dimensions sufficient shear should be exerted on the larger gas cells that initially are formed. Factors influencing this shear are the type of mixer or beater or whisk, the viscosity of the liquid medium and the temperature thereof.
In practice a high shear, mixer, such as a Kenwood Chef mixer, a colloid mill, an Oakes mixer, a cavity transfer mixer or a Silverson will be used. By increasing the viscosity and/or lowering the temperature of the liquid medium the size reducing effect of the mixer on the gas cells is increased. If a Kenwood Chef mixer is used at room temperature a suitable dynamic viscosity of the liquid medium is preferably from 0.1 Pa.s to 20 Pa.s although the range of from 0.2 to 0.4 Pa.s is preferred.
Having obtained the gas cells in the form of a thick creamy foam, this foam is then aged. Stable gas, cells may then be separated from part of the liquid medium used for preparing the cells. Separation can be achieved by centrifuging or using a dialysis membrane after modifying the liquid phase of the gas cell suspension such as by dilution with a miscible fluid.
It has now been found that stable gas cells, prepared as a separate ingredient, for example as described above can advantageously be incorporated into cosmetic and pharmaceutical compositions.
The use of this gas cells ingredient in the compositions of the invention provides improved creaminess in texture, a whiter more opaque product and, dependent on components, enhanced fragrance, flavour, or improved skin or mouthfeel. Having similar particle size to an oil or fat emulsion, suspensions of gas cells prepared as described can be used to replace, or improve on, some of the attributes normally contributed by the oil/fat in cosmetic or pharmaceutical emulsions.
DEFINITION OF THE INVENTION
Accordingly, the invention provides a cosmetic or pharmaceutical composition comprising a preformed gas cells ingredient comprising a surfactant, in which the gas cells have a d3,2 average particle size of less than 20μm and a stability in excess of 2 weeks. DISCLOSURE OF THE INVENTION
The invention is founded on the preparation of an ingredient comprising a large number of very stable gas cells of very small size. When such cells are present in bulk they will form about 108 to about 1010 per ml. On incorporation of this ingredient into a cosmetic or pharmaceutical composition, it is preferably distributed throughout the mass in the form of discrete cells so as to provide the benefits associated with their presence. However it must be expected that the cells are lilekly to form flocculates in the composition. The stable gas cells, whether present in discrete form or as flocculates, are distinguished from any gas cells of a larger size that may be present. The latter is not in the form of stable cells, but contributes most of the volume. Usually the gas cell number concentration in the composition will be above about 106 per ml, preferably above 107 per ml, with the number and size selected to provide the desired benefit. The particle size of the gas cells is less than 20μm, more preferred 0.1 to 10μm, most preferred from 1 to 6μm.
The gas cells ingredient for use in compositions of the invention have a stability in excess of 2 weeks. With this is meant that upon storage for 2 weeks at 4°C more than 90% by number of the gas cells in the composition still remain intact. Especially preferred are compositions, wherein the stability of the gas cells is more than 4 weeks, most preferably more than 8 weeks.
The gas cells ingredient can be prepared from a cosmetically acceptable surface active material suitable for the making of gas cells with structured surfaces, that is a surfactant whose head group does not carry a substantial charge, compared to that of an ionised anionic or cationic surfactant, and whose head group also occupies a similar surface area to that of the tail group, such that the tail group is capable of crystallising at the storage temperature of the composition. Preferably, the tail group of the surfactant is saturated and has a carbon chain of at least 14, preferably from 16 to 22 carbon atoms, for products to be held at room temperature or slightly higher. Suitable surfactants are nonionic or virtually so in character, for example mono-, di- or tri-long chain fatty acid esters of sucrose or distearoyl or dipalmitoyl phosphatidylcholine or mixtures thereof.
If desired any suitable thickener may be present in the system while forming the stable gas cells. Suitable thickener materials are for example sugars, (hydroxy-alkyl) celluloses, hydrolysed starches and mixtures thereof.
For preparing compositions containing the gas cells in accordance to the invention, it is desirable to prepare the gas cells in bulk separately and add these as an ingredient to the composition during or after its preparation.
A suitable method of pre-preparing the gas cells ingredient involves the preparation of an aqueous solution of the desired viscosity (for example by using a thickener material at a suitable level) and containing 0.1 to 20 wt% of surfactant (s). In this context it is believed to be within the ability of the skilled person to select those thickeners that will be capable of contributing to the desired viscosity of the aqueous solution. The selection of the surfactant is critical to the subsequent stability of the gas cells. It is restricted to those providing the surface characteristics as described earlier. Gas cells are mechanically incorporated into the aqueous solution and then comminuted by suitable agitation, preferably at high shear, until a system is formed wherein the average particle size of the gas cells is within the limits as herein before described. By taking the appropriate surfactant phase with water or other solutes at low levels, gas cells according to the invention can if desired "be manufactured without the use of a separate component to contribute the principal part of the viscosity. The cosmetic or pharmaceutical compositions of the invention into which the gas cells are incorporated, as a separate ingredient can be any composition which is suitable for topical application to the skin, hair, mucosae or the teeth. The ingredients of such composition in addition to the gas cells, will be those that are conventionally employed by manufacturers and formulations of cosmetic and pharmaceutical compositions.
According to a particularly preferred embodiment of the invention, the gas cells can be employed to enhance delivery, during topical application, of active materials that can benefit the skin, hair, mucosae or teeth.
For example, it has been shown that co-surfactants containing suitable lipid chains may be incorporated into the structured gas cell surface. In this state, the co surfactant is molecularly dispersed within the interface.
The stable gas cells therefore provide a favourable vehicle both to hold and to deposit beneficial surface active species onto a surface. For example species such as ceramides may be included into and deposited from such structures.
When the composition is in liquid or semi liquid form, the gas cells can be employed to enhance the appearance of the composition. Thus, because of their size (of the order of the wavelength of light) and the refractive index difference between the gas phase and the supporting liquid, gas cells of the present invention scatter light very effectively. Consequently, a concentrated suspension for example, greater than 107 cells ml-1 when present in a suitable support medium can be used as a barrier to light radiation. Such cells can be used to replace or augment organic sunscreens or solid inorganic pigments, such as ultra fine titanium dioxide, which are currently used in sunscreen creams and lotions.
The amount of gas cells that can usefully be incorporated into compositions in accordance with the invention, as a preformed gas cells ingredient is from 0.001 to 80%, preferably from 0.1 to 10% by volume of the composition.
ILLUSTRATION OF THE GAS CELLS
Accompanying Figures 1 to 6 show electron micrographs of domed and differently structured gas cells which feature in the composition according to the invention, each shown at a different magnification factor.
EXPERIMENTS Experiments 1 to 4 illustrate the preparation of the gas cells ingredient for subsequent incorporation into compositions of the invention.
Experiment 1
An aqueous solution was prepared containing 70% by wt of maltodextrin 63DE and 2% by wt of sucrose mono stearate ester. Using a Kenwood chef mixer this solution was whipped with air for l hour at speed 5. A thick creamy foam resulted.
This foam showed an air phase volume of 0.6 and the great majority of the gas cells had a diameter of the order of 2μm and below. On standing for 40 days little visible change had occurred in these cells.
Electron microscopy photographs showed (see Figures 1 and 2) that the air cells had surfaces compartmentalised into domes, most of the domes having a hexagonal and some pentagonal outline. Few showed a differently polygonal outline: See in particular, Figure 2. A representation showing part of a domed surface and made with the largest magnification factor is shown in Fig 3.
The foam as prepared could be diluted 1000 times with water resulting in a white milky liquid. The same result was obtained on 1000 times dilution with a 30% by wt aqueous maltodextrin 63DE solution. Though no longer suspended/dispersed in a thick viscous aqueous liquid the gas cells with diameters less than 5-10μm remained in suspension, although with some creaming. This creaming could be reversed by simple stirring or swirling. No significant change took place over 20 days.
Even though some flocculation of cells occurred over extended times (normally greater than several days depending on ionic concentration) the cells remained essentially stable with respect to disproportionation. Flocculation did however cause an increase in the rate of creaming of the gas cell suspension. When not flocculated the cells smaller than 10μm can be seen to be strongly under the influence of Brownian motion, showing that the stability of these cells does not result from the cells being constrained in a rigid matrix.
The gas cells could be concentrated again to a gas phase volume of 0.4 by centrifuging the diluted liquid in a centrifuge at a speed of 2500 rpm for 5 minutes. As expected, the rate of concentration of the gas cells by centrifugation could be manipulated by varying the viscosity of the suspending phase and by the magnitude of the applied gravitational force.
The thick foam prepared by the method just described was diluted with distilled water to air phase volumes Φ of 0.1, 0.01 and 0.001 respectively. After standing for 14 days, gas cell size determinations were made both with a Coulter Counter (aperture size 70μm) and a Malvern Zetasizer.
For the Coulter Counter determination, samples of each of the three amounts of diluted foams were taken after gently shaking and these samples were diluted with distilled water to a dilution suitable for the determination.
The results were as follows:
Phase volume Φ0.1
Figure imgf000012_0001
Phase volume Φ0.1
Figure imgf000012_0002
Phase volume Φ0.1
Figure imgf000013_0001
A blank gas cell size determination of distilled water resulted in a total background count from particulate impurities of 600.
An amount of the original foam was diluted with distilled water to an air phase volume of 0.05 and dialysed against distilled water overnight to reduce the maltodextrin in the liquid phase.
After suitable dilution the following data were obtained for gas cell size distribution using a Malvern Zetasizer.
Figure imgf000014_0001
The same dialysed sample, gently sonicated in an ultrasonic cleaning bath, was subjected to a particle size determination in a Malvern Zetasizer, giving the following data:
Figure imgf000014_0002
These gas cells sizes and distributions are all confirming that the major amount of gas cells is well under10μm size.
Experiment 2
An aqueous solution containing 1.5% (w/w) hydroxy- ethylcellulose and 6% (w/w) sucrose ester, S-1670 Ryoto Sugar Ester ex Mitsubishi Kasei Food Corporation, which is a mixture of predominantly sucrose mono and distearates was aerated in the bowl of a planetary mixer using a fine wire whisk. After 30 minutes the concentration of sucrose esters was increased by 2% by the addition of a more concentrated aqueous solution (25% w/w). Subsequent identical additions were made during whipping at 10 minute intervals until the sucrose ester concentration reached 12% w/w on the total. The overall viscosity of the aerated matrix was maintained approximately constant by the addition of an appropriate amount of water. Optionally, gas cell suspensions prepared in this manner could be processed through a colloid mill to remove quickly the larger gas cells.
Two gas cell suspensions so formed were allowed to stand for 1 hour and subsequently for 1 day. After 100 fold dilutions of both samples no change could be recorded over time in the gas cell size distribution as measured by light microscopy. Observed in this way, gas microcells had typical diameters in the range 1 to 10μm. By light microscopy the microcells could be seen to be freely mobile both in the flowing liquid on the microscope slide and to be moving under the influence of Brownian motion. By increasing the surfactant concentration in this way, an increased proportion of gas microcells relative to larger cells could be formed. After dilution to a viscosity which allowed removal of cells larger than the required size (in this case 20μm) and separation by creaming, the gas cell suspension had a phase volume of gas of ~0.4 and contained in the region of 109 cells per ml. If required, excess surfactant could be removed by dialysis.
Gas microcells prepared in this way could be mixed with solutions containing a gelling or a viscosity imparting agent with appropriate yield strength properties to produce a suspension of known phase volume which is substantially stable to creaming of the cells. With suitable microbiological precautions the gas cell suspension remained unchanged over a period of many weeks.
Experiment 3
Gas microcells have been prepared using a mixture of two types of surfactants having different head group sizes but the same or very similar saturated hydrophobic chains. This experiment illustrates that microcells of substantial stability can be prepared by the addition of various amounts of co-surfactant(s) in which the characteristic surface dome features can be expanded such that the radius of the dome is modified to become more (or less) similar to that of the gas cell surface. This can be illustrated by transmission electron micrograph (Figure 4). The sample was prepared by the procedure of Experiment 1 but from a composition of surfactants of sucrose ester (1.3 w/v) and stearic acid (0.07% w/v). In such microcells the regular pattern is disturbed. Whilst the cell surface remains curved and separated into domains, these are no longer regular. An otherwise identical preparation, but this time containing 1.3% w/v sucrose ester and 0.7% stearic acid, produced gas microcells containing essentially smooth surfaces with only a few lines or discontinuities separating the curved surfaces. Many cells showed no separate regions. After ageing for 13 days and separation of the microcells by 10 times dilution and removal of the larger cells by creaming, the microcells, in two separate determinations of size distribution gave a d3,2 of 1.19 and li.25μm for the dispersion. Microcells in these experiments showed stability characteristics analogous to those microcells described above. Experiment 4
Defatted and fully hydrogenated phosphatidylcholine (PC) (98% pure and containing 1% lysophosphatidylcholine plus other phospholipids as impurities (Emulmetic 950 ex Lucas Meyer)) was used in a small scale preparation of gas microcells. 0.5g PC was heated to 65°C in 10g of 60% maltodextrin solution. A homogenous dispersion was prepared by stirring whilst controlling the temperature for 1 hour. Further dispersion using an ultrasonic probe was used in a second run with similar results. The suspension was aerated at room temperature for 1 hour using a microscale whipping apparatus comprising a cage of stainless steel wires driven by a variable speed motor. A phase volume of typically 0.7 was obtained in the initial aeration step. After ageing for 24 hours the foam comprising microcells could be stripped of the larger cells by creaming. The microcells when viewed by transmission electron microscopy had surfaces characterised by the presence of waves or wrinkles (Figure 6) and frequently deviated substantially from an overall spherical (Figure 5). Cells in the range 1 to 20μm could be harvested by standard separation techniques.
EXAMPLES
The invention is illustrated by Examples 1 and 2 which define skin cream compositions, each containing a preformed gas microcell suspension prepared as described in Experiment 1. Example 1
This example illustrates an oil-in-water skin cream in accordance with the invention.
An oil-in-water cream emulsion having the following formulation was prepared:
% w/w
Mineral oil 4
Gas microcell suspension (Experiment 1) 10
Ceramide 0.01
Brij 56(1) 4
Alfol 16RD(2) 4
Triethanolamine 0.75
Butane-1,3-diol 3
Xanthan gum 0.3
Preservative 0.4
Perfume qs
Butylated hydroxy toluene 0.01
Water to 100
(1) Brij 56 is cetyl alcohol POE (10)
(2) Alfol 16RD is cetyl alcohol
Example 2
This example illustrates a suncare cream in accordance with the invention. The suncare cream had the following formulation:
% w/w
2-hydroxy-n-octanoic acid 1
Gas microcell suspension (Experiment 1) 20
Silicone oil 200 mPas 7.5
Glycerylmonostearate 3
Cetosteryl alcohol 1.6
Polyoxyethylene-(20)-cetyl alcohol 1.4
Xanthan gum 0.5
PARSOL 1789(3) 1.5
PARSOL MCX(4) 7
Perfume qs
Colour qs
Water to 100
(3) PARSOL 1789 is 4-(1,1-dimethylethyl)-4'- methoxydibenzoylmethane (4) PARSOL MCX is octyl methoxycinnamate

Claims

1. A cosmetic or pharmaceutical composition comprising a preformed gas cells ingredient comprising a surfactant, in which the gas cells have a d3,2 average particle size of less than 20μm and a stability in excess of 2 weeks.
2. A composition according to claim 1, wherein the d3,2 average particle size of the gas cells is from 0.1 to 10μm.
3. A composition according to claim 1, wherein the d3,2 average particle size of the gas cells is from 0.5 to 3μm.
4. A composition according to claim 1, 2 or 3, in which the surfactant is chosen from those whose head group does not carry a substantial charge, compared to that of an anionic or cationic surfactant.
5. A composition according to any preceding claim, in which the surfactant is chosen from those whose head group occupies a similar surface area to that of the tail group.
6. A composition according to any preceding claim, in which the surfactant is chosen from those whose tail group is capable of crystallising at the storage temperature of the composition.
7. A composition according to any preceding claim, in. which the tail group has a carbon chain of at least 14 carbon atoms.
8. A composition according to claim 7, in which the carbon chain comprises from 16 to 22 carbon atoms.
9. A composition according to any preceding claim in which the surfactant is a nonionic surfactant.
10. A composition according to any preceding claim, in which the surfactant is a mono-, di-or tri-long chain fatty acid ester of sucrose.
11. A composition according to any of claims 1 to 9, in which the surfactant is chosen from distearoyl phosphatidylcholine, dipalmitoyl phosphatidylcholine and mixtures thereof.
12. A composition according to any preceding claim, in which the preformed gas cells ingredient further comprises a thickener.
13. A composition according to claim 12, in which the thickener is chosen from sugars, (hydroxyalkyl) cellulose, hydrolysed starches and mixtures thereof.
PCT/EP1993/003358 1992-12-02 1993-11-27 Cosmetic composition WO1994012145A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU56293/94A AU5629394A (en) 1992-12-02 1993-11-27 Cosmetic composition
JP6512784A JPH08503936A (en) 1992-12-02 1993-11-27 Cosmetic composition
EP94901923A EP0690708A1 (en) 1992-12-02 1993-11-27 Cosmetic composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92311064.7 1992-12-02
EP92311064 1992-12-02

Publications (2)

Publication Number Publication Date
WO1994012145A2 true WO1994012145A2 (en) 1994-06-09
WO1994012145A3 WO1994012145A3 (en) 1994-07-21

Family

ID=8211569

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1993/003358 WO1994012145A2 (en) 1992-12-02 1993-11-27 Cosmetic composition

Country Status (5)

Country Link
EP (1) EP0690708A1 (en)
JP (1) JPH08503936A (en)
AU (1) AU5629394A (en)
CA (1) CA2150488A1 (en)
WO (1) WO1994012145A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003082225A1 (en) * 2002-03-28 2003-10-09 Hakuto Co., Ltd. Method of foam stabilization for foam cosmetic
US9193852B2 (en) 2013-12-27 2015-11-24 L'oreal Stable aerated compositions

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3652549B2 (en) * 1999-06-14 2005-05-25 株式会社コーセー Cosmetics
ES2524120T3 (en) * 2010-12-28 2014-12-04 Unilever N.V. Method for the production of an emulsion

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0077752A2 (en) * 1981-10-16 1983-04-27 Schering Aktiengesellschaft Liquid mixture for absorbing and stabilizing gas bubbles to be used as contrast agent in ultrasonic diagnosis and process for its preparation
EP0138460A2 (en) * 1983-09-28 1985-04-24 Unilever Plc Toothpaste with entrained gas
US4684479A (en) * 1985-08-14 1987-08-04 Arrigo Joseph S D Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures
EP0320433A2 (en) * 1987-12-02 1989-06-14 Schering Aktiengesellschaft Process using ultrasonic or shock waves, and means for carrying it out
CH674804A5 (en) * 1988-02-05 1990-07-31 Battelle Memorial Institute Homogeneous stale cosmetic cream as light foam - contains dispersed fine bubbles of air or inert gas
WO1991015244A2 (en) * 1990-04-02 1991-10-17 Sintetica S.A. Stable microbubbles suspensions injectable into living organisms
WO1992005806A1 (en) * 1990-10-05 1992-04-16 Sintetica S.A. Method for the preparation of stable suspensions of hollow gas-filled microspheres suitable for ultrasonic echography
WO1992015284A1 (en) * 1991-03-01 1992-09-17 Micro Vesicular Systems, Inc. Gas and oxygen carrying lipid vesicles
WO1992021255A1 (en) * 1991-06-03 1992-12-10 Unilever N.V. Gas cells in a liquid medium

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0077752A2 (en) * 1981-10-16 1983-04-27 Schering Aktiengesellschaft Liquid mixture for absorbing and stabilizing gas bubbles to be used as contrast agent in ultrasonic diagnosis and process for its preparation
EP0138460A2 (en) * 1983-09-28 1985-04-24 Unilever Plc Toothpaste with entrained gas
US4684479A (en) * 1985-08-14 1987-08-04 Arrigo Joseph S D Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures
EP0320433A2 (en) * 1987-12-02 1989-06-14 Schering Aktiengesellschaft Process using ultrasonic or shock waves, and means for carrying it out
CH674804A5 (en) * 1988-02-05 1990-07-31 Battelle Memorial Institute Homogeneous stale cosmetic cream as light foam - contains dispersed fine bubbles of air or inert gas
WO1991015244A2 (en) * 1990-04-02 1991-10-17 Sintetica S.A. Stable microbubbles suspensions injectable into living organisms
WO1992005806A1 (en) * 1990-10-05 1992-04-16 Sintetica S.A. Method for the preparation of stable suspensions of hollow gas-filled microspheres suitable for ultrasonic echography
WO1992015284A1 (en) * 1991-03-01 1992-09-17 Micro Vesicular Systems, Inc. Gas and oxygen carrying lipid vesicles
WO1992021255A1 (en) * 1991-06-03 1992-12-10 Unilever N.V. Gas cells in a liquid medium

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003082225A1 (en) * 2002-03-28 2003-10-09 Hakuto Co., Ltd. Method of foam stabilization for foam cosmetic
US9193852B2 (en) 2013-12-27 2015-11-24 L'oreal Stable aerated compositions

Also Published As

Publication number Publication date
JPH08503936A (en) 1996-04-30
CA2150488A1 (en) 1994-06-09
AU5629394A (en) 1994-06-22
EP0690708A1 (en) 1996-01-10
WO1994012145A3 (en) 1994-07-21

Similar Documents

Publication Publication Date Title
DE69433386T2 (en) Propylene glycol stearate vesicles
US5976604A (en) Oil-in-water emulsion composition having high oil content and method for producing the same
CA2110493C (en) Gas cells in a liquid medium
JPH08245338A (en) Acidic composition based on lipid endoplasmic reticulum and method for use of it
JP2000178129A (en) Nano-emulsion based on mixed ester of fatty acid or fatty alcohol, carboxylic acid and glycerol and its use in cosmetic, dermatological and/or ophthalmic field
Förster et al. Emulsification by the phase inversion temperature method: the role of self‐bodying agents and the influence of oil polarity
CA2150687C (en) Frozen confections
US5405615A (en) Sucrose distearate lipid vesicles
AU2004271753A1 (en) Concentrated and diluted stable oil/water emulsions
Tadros Colloid aspects of cosmetic formulations with particular reference to polymeric surfactants
JP4820002B2 (en) Glucosid pouch lamella vesicle
WO1994012145A2 (en) Cosmetic composition
JPS586530B2 (en) composite emulsion
EP0667767B1 (en) Method for the preparation of creams
JPH09294927A (en) Oil-in-water type emulsion composition of high oil content and its preparation
JPH0532522A (en) Production of cosmetic and additive for cosmetic
JPH0899853A (en) Skin cosmetic
JPH09239258A (en) Film composition
JP2001354515A (en) Composite emulsion and cosmetic formulated with the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AT AU BB BG BR BY CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU LV MG MN MW NL NO NZ PL PT RO RU SD SE SK UA UZ VN

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AT AU BB BG BR BY CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU LV MG MN MW NL NO NZ PL PT RO RU SD SE SK UA UZ VN

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2150488

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1994901923

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 258564

Country of ref document: NZ

WWP Wipo information: published in national office

Ref document number: 1994901923

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1994901923

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642